Abstract: The present invention relates to a selective reduction of esters to their corresponding alcohols.

Abstract: The invention relates to an improved process for the manufacture of bis-resorcinyl triazines of formula (I), wherein R1 is hydrogen, a C1-C18alkyl group or a C2-C18alkenyl group and R2 is a C1-C18alkyl group or a C2-C18alkenyl group.

Abstract: Hybrid rope (1) having a core containing synthetic yarns (5), surrounded by an outer containing steel wire strands (5), the rope being terminated at least at one of its ends by a socket (2) having a conically shaped space (3), which has a conical angle ? of between 2 and 8° and a length of between 5D and 20D, D being the smallest diameter of the conically shaped space, the core containing synthetic yarns and the steel wires having been untwisted at said at least one of the ends, the open space (6) around the untwisted wires and fibers in the hollow conical body of the socket being filled with a resin.

Abstract: The invention relates to a heat-curable powder coating composition comprising i) at least one crystalline polyester resin present in an amount of at most 90 wt %; and ii) at least one amorphous polyester resin; and iii) at least one crosslinking agent; and iv) at least one thermal radical initiator, wherein, the at least one crystalline polyester resin and/or the at least one amorphous polyester resin has di-acid ethylenic unsaturations; wherein the at least one crosslinking agent is either crystalline or amorphous; wherein the at least one crosslinking agent has reactive unsaturations that are reactable with the ethylenic unsaturations of the di-acid ethylenic unsaturations of the at least one crystalline polyester resin and/or the at least one amorphous polyester resin to be crosslinked, said unsaturations of the crosslinking agent are different from the unsaturations of the at least one crystalline polyester resin and the unsaturations of the at least amorphous polyester resin; wherein the wt % is based on

Abstract: A detection arrangement for detecting presence of an analyte in a sample includes a processor, a memory, a display, a color measuring device, and a temperature controller for maintaining a constant temperature or a temperature profile of the sample. A method is also provided for determining the presence or absence of an analyte in a fluid by analysis of image data from an assay that generates an image result on an assay medium.

Abstract: The invention relates to a process for the preparation of a polymer comprising at least one aliphatic or aromatic hydrocarbyl C2-20 olefin in the presence of an ionic catalyst comprising an organometallic compound and an activator, and optionally a scavenger, characterized in that the organometallic compound is a compound according to formula (1): where: M is a metal of group 3, 4, 5, 6 or 7, or the lanthanide series, and p is the valency of the metal M, A represents a neutral or anionic spectator ligand whose valency v is 0, 1 or 2, and q is an integer denoting the number of spectator ligands A, Z is an optional bridging moiety, n is the integer number of parallel bridging moieties Z, Y is an amidine-containing spectator ligand represented by formula (2): wherein the amidine-containing ligand is covalently bonded to the metal M via the imine nitrogen atom, Sub1 is a substituent, which comprises a group 14 atom through which Sub1 is bonded to the imine carbon atom.

Abstract: The invention relates to a process for the production of a biological substance by perfusion culturing of suspended animal cells in a serum free cell culture medium, wherein the biological substance is separated from the cells by filtration, characterized in that at least 0.001 w/w % nonionic surfactant is present in the cell culture medium. It has been found that the presence of nonionic surfactant in the cell culture medium improves the filter performance.

Abstract: The invention is concerned with the use of lycopene, optionally in combination with vitamin E and/or C or other biologically active ingredients as disclosed in the specification, in the manufacture of a composition for the primary and secondary prevention of angiogenesis-associated pathologies and coadjuvant treatment thereof; as well as with particular novel formulations comprising lycopene.